FGF-9参与调控小鼠上颌突间充质细胞体外成骨分化的研究

doi:10.3969/j.issn.1005-4979.2014.06.003

摘要/Abstract

摘要： 目的：研究成纤维细胞生长因子9（FGF-9）对体外培养的小鼠上颌突间充质细胞成骨分化的调控作用。方法：体外培养E12.5（胚胎第12.5天）的小鼠上颌突间充质细胞，取第1代细胞进行成骨诱导，实验组加入FGF-9人重组蛋白，诱导培养1周后通过qPCR、免疫荧光和茜素红染色检测其成骨能力。结果：体外培养的E12.5小鼠上颌突间充质细胞表达FGF9和FGFR3。成骨诱导可促进上颌突间充质细胞表达成骨标记物ALP、Runx2和OCN；加入FGF-9人重组蛋白可降低成骨标记物ALP、Runx2和OCN的表达，减少钙结节形成。结论：体外培养时，FGF9参与负调控上颌突间充质细胞的成骨分化。

关键词: 成纤维细胞生长因子9（FGF-9）, 上颌突间充质细胞, 成骨分化, 鼠

Abstract: Objective: To investigate the regulatory effect of FGF-9 for the osteogenic differentiation of mouse maxillary primordium mesenchymal cells (MPMCs) cultured in vitro. Methods: MPMCs were obtained from the E12.5 embryos and cultured in vitro. Cells of the primary passage were cultured in the osteogenic medium for 1 week, and 10 nmol/L FGF-9 human recombinant protein was added in the medium in experimental group. qPCR，immunofluorescence staining and Alizarin red staining were used to evaluate the osteogenic capability of MPMCs. Results: E12.5 MPMCs expressed positive FGF-9 and FGFR-3 protein in vitro. Osteogenic induction could stimulate the expression of osteogenic markers, including ALP, Runx2 and OCN. However, exogenous FGF-9 could inhibit the expression of ALP, Runx2 and OCN, and reduced the formation of calcium nodules simultaneously in MPMCs. Conclusion: FGF-9 can negatively regulate the osteogenic differentiation of MPMCs in vitro.

Key words: fibroblast growth favtor 9（FGF-9）, maxillary primordium mesenchymal cells, osteogenic differentiation, rats

中图分类号:

李金超，刘继光，刘茁，高子龙，江欣，李守宏. FGF-9参与调控小鼠上颌突间充质细胞体外成骨分化的研究[J]. 《口腔颌面外科杂志》, 2014, 24(6): 413-.

LI Jin-chao, LIU Ji-guang, LIU Zhuo, GAO Zi-long, JIANG Xin, LI Shou-hong. FGF-9 Regulates Osteogenic Differentiation of Mouse Maxillary Primordium Mesenchymal Cells[J]. 《Journal of Oral and Maxillofacial Surgery》, 2014, 24(6): 413-.

https://journal06.magtech.org.cn/Jweb_joms/CN/Y2014/V24/I6/413

参考文献

[1] Santos-Ocampo S, Colvin JS, Chellaiah A, et al. Expression and biological activity of mouse fibroblast growth factor-9[J]. J Biol Chem, 1996, 271(3):1726-1731.

[2] Hecht D, Zimmerman N, Bedford M, et al. Identification of fibroblast growth factor 9 (FGF9) as a high affinity, heparin dependent ligand for FGF receptors 3 and 2 but not for FGF receptors 1 and 4 [J]. Growth Factors, 1995, 12(3):223-233.

[3] Robinson D, Hasharoni A, Oganesian A, et al. Role of FGF9 and FGF receptor 3 in osteochondroma formation [J]. Orthopedics, 2001, 24(8):783-778.

[4] Weksler NB, Lunstrum GP, Reid ES, et al. Differential effects of fibroblast growth factor (FGF) 9 and FGF2 on proliferation, differentiation and terminal differentiation of chondrocytic cells in vitro[J]. Biochem J, 1999, 342(Pt 3):677-682.

[5] Garofalo S, Kliger-Spatz M, Cooke JL, et al. Skeletal dysplasia and defective chondrocyte differentiation by targeted overexpression of fibroblast growth factor 9 in transgenic mice [J]. J Bone Miner Res, 1999,14(11):1909-1915.

[6] Wu XL, Gu MM, Huang L, et al. Multiple synostoses syndrome is due to a missense mutation in exon 2 of FGF9 gene [J]. Am J Hum Genet, 2009, 85(1):53-63.

[7] White AC, Lavine KJ, Ornitz DM. FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network[J]. Development, 2007,134(20):3743-3752.

[8] Govindarajan V, Overbeek PA. FGF9 can induce endochondral ossification in cranial mesenchyme[J]. BMC Dev Biol, 2006, 6:7.

[9] Hung IH, Yu K, Lavine KJ, et al. FGF9 regulates early hypertrophic chondrocyte differentiation and skeletal vascularization in the developing stylopod[J]. Dev Biol, 2007, 307(2): 300-313.

[10] Knight RD, Schilling TF. Cranial neural crest and development of the head skeleton[J]. Adv Exp Med Biol, 2006, 589:120-133.

[11] Chai Y, Maxson RE, Jr. Recent advances in craniofacial morphogenesis [J]. Dev Dyn, 2006, 235(9):2353-2375.

[12] Pan K, Sun Q, Zhang J, et al. Multilineage differentiation of dental follicle cells and the roles of Runx2 over-expression in enhancing osteoblast/cementoblast-related gene expression in dental follicle cells[J]. Cell Prolif, 2010, 43(3):219-228.

[13] Dai J, Wang J, Lu J, et al. The effect of co-culturing costal chondrocytes and dental pulp stem cells combined with exogenous FGF9 protein on chondrogenesis and ossification in engineered cartilage[J]. Biomaterials, 2012, 33(31):7699-7711.

[14] Behr B, Leucht P, Longaker MT, et al. Fgf-9 is required for angiogenesis and osteogenesis in long bone repair[J]. Proc Natl Acad Sci U S A, 2010, 107(26):11853-11858.

[15] 陈晓怡, 吴晓林, 顾鸣敏, 等. FGF9 转基因小鼠的功能及组织表达谱的研究[J]. 诊断学理论与实践, 2009, 8(5):496-501.

[16] 卢境婷, 沈国芳. 颅神经嵴细胞迁移的调控[J]. 口腔颌面外科杂志, 2012, 22(1):64-67.

[17] 吕红兵. 颅神经嵴细胞向成骨细胞表型分化的诱导实验[J]. 牙体牙髓牙周病学杂志, 2002,12(8):410-412.

[18] Alappat S, Zhang ZY, Chen YP. Msx homeobox gene family and craniofacial development[J]. Cell Res, 2003, 13(6):429-442.

[19] Kim HJ, Rice DP, Kettunen PJ, et al. FGF-, BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development[J]. Development, 1998, 125(7):1241-1251.

[20] Fakhry A, Ratisoontorn C, Vedhachalam C, et al. Effects of FGF-2/-9 in calvarial bone cell cultures: differentiation stage-dependent mitogenic effect, inverse regulation of BMP-2 and noggin, and enhancement of osteogenic potential [J]. Bone, 2005, 36(2):254-266.

选择文件类型/文献管理软件名称

选择包含的内容